Drug Manufacturers - Specialty & Generic
AVDL
16.52
price up icon4.36%   +0.69
after-market  After Hours:  16.8999  0.3799   +2.30%

Avadel Pharmaceuticals plc ADR (AVDL)
loading
Overview News Price History Option Chain Financials Why AVDL Down? Discussions Forecast

Why is Avadel Pharmaceuticals plc ADR (AVDL) Stock down?

We've noticed a 10.62% decline in Avadel Pharmaceuticals plc ADR (AVDL) stock during the 2024-05-08 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!
23 Jun, 2023:

AVDL's stock fell 11.41% following Jazz Pharmaceuticals' lawsuit against the FDA for violating the orphan drug exclusivity of Xywav by approving Avadel Pharmaceuticals' Lumryz, which is an extended-release reformulation of its high sodium oxybate product Xyrem for narcolepsy.

https://www.benzinga.com/general/biotech/23/06/32982101/jazz-pharmaceuticals-sues-fda-over-approval-of-rival-product-calls-it-unlawful

Similar to AVDL

drug_manufacturers_specialty_generic ITCI
$64.96
price down icon 0.92%
drug_manufacturers_specialty_generic ELAN
$17.00
price down icon 1.16%
drug_manufacturers_specialty_generic CTLT
$55.81
price down icon 0.30%
drug_manufacturers_specialty_generic RDY
$69.17
price down icon 0.42%
drug_manufacturers_specialty_generic VTRS
$11.16
price down icon 0.53%
drug_manufacturers_specialty_generic NBIX
$136.70
price down icon 2.12%
Open in Yahoo | Open in Google | Open in Finviz
Cap:     |  Volume (24h):